SCHEMBL6780786

SCHEMBL6780786

C#CCNC(=O)N1CC(c2ccc(Cl)c(Cl)c2)C1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.44
TP53 P04637 2/20 0.44
MAPT P10636 2/20 0.44
SLC6A2 P23975 9/20 0.42
SLC6A4 P31645 9/20 0.42
SLC6A3 Q01959 9/20 0.42
KCNH2 Q12809 7/20 0.42
EPHX2 P34913 1/20 0.41
JAK1 P23458 1/20 0.41
TYK2 P29597 1/20 0.41
HRH3 Q9Y5N1 2/20 0.40
CYP2D6 P10635 4/20 0.39
CCR2 P41597 2/20 0.38
DPP4 P27487 1/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
CHRNA7 P36544 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6783635 0.85 MAPT (0.42) LMNATP53MAPTDPP4NPC1
SCHEMBL7113402 0.81 HRH3 (0.44) LMNATP53MAPTSLC6A2SLC6A4
SCHEMBL7536178 0.81 HRH3 (0.44) LMNATP53MAPTSLC6A2SLC6A4
SCHEMBL7113404 0.81 HRH3 (0.44) LMNATP53MAPTSLC6A2SLC6A4
SCHEMBL6778327 0.80 NPC1 (0.46) MAPTNPC1RAB9A
SCHEMBL9596853 0.79 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3KCNH2EPHX2
SCHEMBL6774253 0.78 ACACB (0.43) SLC6A2MEN1RAB9AKMT2A
SCHEMBL6779924 0.77 CHRM2 (0.43) MAPTKCNH2MEN1KMT2A
SCHEMBL6780159 0.76 GRIN2B (0.47) CCR2MEN1KMT2A
SCHEMBL25222714 0.69 PDE4B (0.48) SLC6A2SLC6A4SLC6A3KCNH2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6831078-B1 3-aryl substituted having halo or alkylhalo groups; anxiety, epilepsy; presurgery muscle relaxant VERNALIS RESEARCH LIMITED (GB) 2004-12-14 US disclosed
EP-1049670-B1 AZETIDINECARBOXAMIDE DERIVATIVES FOR TREATING CNS DISORDERS VERNALIS RES LTD (GB) 2002-07-17 EP disclosed
EP-1049670-A1 AZETIDINECARBOXAMIDE DERIVATIVES FOR TREATING CNS DISORDERS VERNALIS RESEARCH LIMITED (GB) 2000-11-08 EP disclosed
WO-1999037613-A1 AZETIDINECARBOXAMIDE DERIVATIVES FOR TREATING CNS DISORDERS VERNALIS RESEARCH LIMITED (GB) 1999-07-29 WO disclosed